Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jeffrey W Bird. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jeffrey W Bird har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| Director | 0 | |
| US:FTSV / Forty Seven, Inc. | Director | 0 |
| US:HAIR / Restoration Robotics, Inc. | Director | 13 708 |
| US:PSTG / Everpure, Inc. | 10% Owner | 499 478 |
| US:YEXT / Yext, Inc. | 10% Owner | 0 |
| US:MATR / Mattersight Corp. | 10% Owner | 1 056 194 |
| US:THLD / Threshold Pharmaceuticals, Inc. | Director | 377 782 |
| US:HZNP / Horizon Therapeutics Plc | Director | 178 406 |
| US:CRDC / Cardica, Inc. | 10% Owner | 3 412 793 |
| US:CORT / Corcept Therapeutics Incorporated | 10% Owner | 0 |
| US:QNST / QuinStreet, Inc. | 10% Owner | 54 547 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jeffrey W Bird. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp CORT / Corcept Therapeutics Incorporated - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp QNST / QuinStreet, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp YEXT / Yext, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i CORT / Corcept Therapeutics Incorporated. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
| Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
|---|---|---|---|---|---|---|---|
| Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jeffrey W Bird som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −10 000 | 0 | −100,00 | ||||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −11 377 | 0 | −100,00 | ||||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 991 | 0 | −100,00 | ||||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 000 | 0 | −100,00 | ||||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −14 101 | 0 | −100,00 | ||||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −458 569 | 0 | −100,00 | 18,00 | −8 254 242 | ||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −45 402 | 0 | −100,00 | 18,00 | −817 236 | ||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −10 007 | 0 | −100,00 | 18,00 | −180 126 | ||
| 2020-07-06 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −20 475 | 0 | −100,00 | 18,00 | −368 550 | ||
| 2020-06-16 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 11 377 | 11 377 | |||||
| 2020-06-16 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
A - Award | 7 281 | 20 475 | 55,18 | ||||
| 2020-04-07 |
|
4 | FTSV |
Forty Seven, Inc.
Stock Option (right to buy) |
D - Sale to Issuer | −10 322 | 0 | −100,00 | ||||
| 2020-04-07 |
|
4 | FTSV |
Forty Seven, Inc.
Stock Option (right to buy) |
D - Sale to Issuer | −20 645 | 0 | −100,00 | ||||
| 2020-04-07 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
D - Sale to Issuer | −6 596 | 0 | −100,00 | ||||
| 2020-04-07 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
D - Sale to Issuer | −215 375 | 0 | −100,00 | ||||
| 2020-04-07 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
D - Sale to Issuer | −233 564 | 0 | −100,00 | ||||
| 2020-04-07 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
D - Sale to Issuer | −562 500 | 0 | −100,00 | ||||
| 2019-09-03 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
J - Other | 9 516 | 458 569 | 2,12 | ||||
| 2019-09-03 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
J - Other | −921 610 | 0 | −100,00 | ||||
| 2019-09-03 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
J - Other | 10 007 | 10 007 | |||||
| 2019-07-24 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
P - Purchase | 187 500 | 192 419 | 3 811,75 | 8,00 | 1 500 000 | 1 539 352 | |
| 2019-07-24 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
P - Purchase | 562 500 | 562 500 | 8,00 | 4 500 000 | 4 500 000 | ||
| 2019-06-17 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 6 991 | 6 991 | |||||
| 2019-06-17 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
A - Award | 4 194 | 13 194 | 46,60 | ||||
| 2019-06-14 |
|
4 | FTSV |
Forty Seven, Inc.
Stock Option (right to buy) |
A - Award | 10 322 | 10 322 | |||||
| 2019-02-11 |
|
5 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
G - Gift | 0 | 45 402 | 0,00 | ||||
| 2018-08-23 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 50 355 | 449 053 | 12,63 | 26,65 | 1 341 810 | 11 965 915 | |
| 2018-08-23 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 202 082 | 398 698 | 102,78 | 26,09 | 5 273 006 | 10 403 386 | |
| 2018-08-23 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 137 563 | 196 616 | 232,95 | 25,17 | 3 462 571 | 4 948 982 | |
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Series A-1 Preferred Stock |
C - Conversion | −667 | 0 | −100,00 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Series B Preferred Stock |
C - Conversion | −945 326 | 0 | −100,00 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Series A-2 Preferred Stock |
C - Conversion | −774 165 | 0 | −100,00 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Series A-1 Preferred Stock |
C - Conversion | −1 052 146 | 0 | −100,00 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Series B Preferred Stock |
C - Conversion | −73 686 | 0 | −100,00 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Series A-2 Preferred Stock |
C - Conversion | −73 159 | 0 | −100,00 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Series A-1 Preferred Stock |
C - Conversion | −68 530 | 0 | −100,00 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
C - Conversion | 667 | 4 919 | 15,69 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
P - Purchase | 4 252 | 4 252 | 16,00 | 68 032 | 68 032 | ||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
P - Purchase | 134 735 | 2 906 372 | 4,86 | 16,00 | 2 155 760 | 46 501 952 | |
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
C - Conversion | 774 165 | 2 771 637 | 38,76 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
C - Conversion | 945 326 | 1 997 472 | 89,85 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
C - Conversion | 1 052 146 | 1 052 146 | |||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
C - Conversion | 68 530 | 215 375 | 46,67 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
C - Conversion | 73 159 | 146 845 | 99,28 | ||||
| 2018-07-03 |
|
4 | FTSV |
Forty Seven, Inc.
Common Stock |
C - Conversion | 73 686 | 73 686 | |||||
| 2018-06-15 |
|
4 | HAIR |
Restoration Robotics, Inc.
Stock Option (Right to Buy) |
A - Award | 13 708 | 13 708 | |||||
| 2018-06-11 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 6 000 | 6 000 | |||||
| 2018-06-11 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
A - Award | 3 000 | 9 000 | 50,00 | ||||
| 2018-02-23 |
|
5 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
G - Gift | 0 | 499 478 | 0,00 | ||||
| 2018-02-13 |
|
5 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
G - Gift | 0 | 36 602 | 0,00 | ||||
| 2017-12-05 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
J - Other | −8 614 633 | 0 | −100,00 | ||||
| 2017-12-05 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
J - Other | 323 049 | 323 049 | |||||
| 2017-12-05 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
J - Other | 78 140 | 78 140 | |||||
| 2017-12-04 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
J - Other | −8 500 000 | 17 102 128 | −33,20 | ||||
| 2017-12-04 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
J - Other | 318 750 | 318 750 | |||||
| 2017-12-04 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
J - Other | 77 100 | 77 100 | |||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Series C Preferred Stock |
C - Conversion | −71 498 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Series B Preferred Stock |
C - Conversion | −31 476 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Series A Preferred Stock |
C - Conversion | −66 684 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Convertible Promissory Note |
C - Conversion | −12 936 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Series C Preferred Stock |
C - Conversion | −888 690 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Series B Preferred Stock |
C - Conversion | −606 386 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Series A Preferred Stock |
C - Conversion | −479 145 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Convertible Promissory Note |
C - Conversion | −105 369 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Series B Preferred Stock |
C - Conversion | −31 747 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Series C Preferred Stock |
C - Conversion | −40 982 | 0 | −100,00 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 12 936 | 182 594 | 7,62 | 7,00 | 90 552 | 1 278 158 | |
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 31 476 | 169 658 | 22,78 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 66 684 | 138 182 | 93,27 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 71 498 | 71 498 | |||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 105 369 | 2 079 590 | 5,34 | 7,00 | 737 583 | 14 557 130 | |
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 479 145 | 1 974 221 | 32,05 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 606 386 | 1 495 076 | 68,23 | ||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 888 690 | 888 690 | |||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 31 747 | 31 747 | |||||
| 2017-10-18 |
|
4 | HAIR |
Restoration Robotics Inc
Common Stock |
C - Conversion | 40 982 | 40 982 | |||||
| 2017-10-13 |
|
4 | HAIR |
Restoration Robotics Inc
Convertible Promissory Note |
J - Other | 90 065,00 | ||||||
| 2017-10-13 |
|
4 | HAIR |
Restoration Robotics Inc
Convertible Promissory Note |
J - Other | 733 569,00 | ||||||
| 2017-07-14 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 6 000 | 6 000 | |||||
| 2017-07-14 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
A - Award | 3 000 | 6 000 | 100,00 | ||||
| 2017-06-02 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 203 543 | 1 056 194 | 23,87 | 3,65 | 742 789 | 3 854 369 | |
| 2017-06-02 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 16 189 | 108 557 | 17,53 | 3,65 | 59 079 | 396 157 | |
| 2017-06-02 |
|
4 | MATR |
Mattersight Corp
Common Stock |
J - Other | −271 391 | 852 651 | −24,14 | ||||
| 2017-06-02 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 110 642 | 921 610 | 13,64 | 31,85 | 3 523 760 | 29 351 712 | |
| 2017-06-02 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
P - Purchase | 8 800 | 45 402 | 24,04 | 31,85 | 280 265 | 1 445 977 | |
| 2017-06-02 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
J - Other | −147 523 | 810 968 | −15,39 | ||||
| 2017-06-02 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
P - Purchase | 37 626 | 377 782 | 11,06 | 0,57 | 21 349 | 214 354 | |
| 2017-06-02 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
P - Purchase | 473 077 | 3 940 573 | 13,64 | 0,57 | 268 424 | 2 235 881 | |
| 2017-06-02 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
J - Other | −630 770 | 3 467 496 | −15,39 | ||||
| 2017-06-02 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
P - Purchase | 3 073 613 | 25 602 128 | 13,64 | 11,08 | 34 047 026 | 283 599 892 | |
| 2017-06-02 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
P - Purchase | 1 024 538 | 1 024 538 | 11,08 | 11 349 012 | 11 349 012 | ||
| 2017-06-02 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
J - Other | −4 098 151 | 22 528 515 | −15,39 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series F Preferred Stock |
C - Conversion | −17 680 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series E Preferred Stock |
C - Conversion | −20 150 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series D Preferred Stock |
C - Conversion | −29 452 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series C Preferred Stock |
C - Conversion | −69 717 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series B Preferred Stock |
C - Conversion | −62 193 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series A Preferred Stock |
C - Conversion | −105 129 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series F Preferred Stock |
C - Conversion | −255 372 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series E Preferred Stock |
C - Conversion | −282 842 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series D Preferred Stock |
C - Conversion | −887 428 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series C Preferred Stock |
C - Conversion | −2 975 941 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series B Preferred Stock |
C - Conversion | −2 654 762 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series A Preferred Stock |
C - Conversion | −2 799 328 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series C Preferred Stock |
C - Conversion | −99 398 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series B Preferred Stock |
C - Conversion | −149 134 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series A Preferred Stock |
C - Conversion | −116 070 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series D Preferred Stock |
C - Conversion | −14 379 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Series C Preferred Stock |
C - Conversion | −21 223 | 0 | −100,00 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 17 680 | 311 959 | 6,01 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 20 150 | 294 279 | 7,35 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 29 452 | 274 129 | 12,04 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 62 193 | 244 677 | 34,08 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 69 717 | 182 484 | 61,82 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 105 129 | 112 767 | 1 376,39 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 255 372 | 10 181 717 | 2,57 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 282 842 | 9 926 345 | 2,93 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 887 428 | 9 643 503 | 10,13 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 2 654 762 | 8 756 075 | 43,51 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 2 799 328 | 6 101 313 | 84,78 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 2 975 941 | 3 301 985 | 912,74 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 99 398 | 377 280 | 35,77 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 116 070 | 277 882 | 71,73 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 149 134 | 161 812 | 1 176,32 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 14 379 | 35 602 | 67,75 | ||||
| 2017-04-21 |
|
4 | YEXT |
Yext, Inc.
Common Stock |
C - Conversion | 21 223 | 21 223 | |||||
| 2017-04-12 | 3 | YEXT |
Yext, Inc.
Common Stock |
359 038 | ||||||||
| 2017-04-12 | 3 | YEXT |
Yext, Inc.
Common Stock |
672 404 | ||||||||
| 2017-04-12 | 3 | YEXT |
Yext, Inc.
Common Stock |
353 998 | ||||||||
| 2017-04-12 | 3 | YEXT |
Yext, Inc.
Common Stock |
359 038 | ||||||||
| 2017-04-12 | 3 | YEXT |
Yext, Inc.
Common Stock |
672 404 | ||||||||
| 2017-04-12 | 3 | YEXT |
Yext, Inc.
Common Stock |
353 998 | ||||||||
| 2017-03-10 |
|
5 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
G - Gift | 0 | 499 478 | 0,00 | ||||
| 2017-03-10 |
|
5 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
G - Gift | 0 | 499 478 | 0,00 | ||||
| 2017-02-13 |
|
5 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
G - Gift | 0 | 36 602 | 0,00 | ||||
| 2017-02-13 |
|
5 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
G - Gift | 0 | 36 602 | 0,00 | ||||
| 2016-06-28 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 35 000 | 35 000 | |||||
| 2016-06-21 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 6 000 | 6 000 | |||||
| 2016-06-21 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
A - Award | 3 000 | 3 000 | |||||
| 2016-03-01 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
J - Other | 96 010 | 340 156 | 39,32 | ||||
| 2016-03-01 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
J - Other | −617 132 | 4 098 266 | −13,09 | ||||
| 2016-01-26 |
|
5 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
| 2015-12-08 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
J - Other | 22 454 | 59 053 | 61,35 | ||||
| 2015-12-08 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
J - Other | −144 333 | 958 491 | −13,09 | ||||
| 2015-11-23 |
|
4 | MATR |
Mattersight Corp
Series B Preferred Stock |
J - Other | 14 976 | 46 823 | 47,02 | ||||
| 2015-11-23 |
|
4 | MATR |
Mattersight Corp
Series B Preferred Stock |
J - Other | −96 261 | 639 253 | −13,09 | ||||
| 2015-11-23 |
|
4 | MATR |
Mattersight Corp
Common Stock |
J - Other | 49 759 | 71 840 | 225,35 | ||||
| 2015-11-23 |
|
4 | MATR |
Mattersight Corp
Common Stock |
J - Other | −319 847 | 1 124 042 | −22,15 | ||||
| 2015-11-12 |
|
4 | MATR |
Mattersight Corp
Common Stock |
S - Sale | −1 000 000 | 1 443 889 | −40,92 | 7,29 | −7 290 000 | 10 525 951 | |
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series F Preferred Stock |
C - Conversion | −115 421 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series E Preferred Stock |
C - Conversion | −140 518 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series D Preferred Stock |
C - Conversion | −123 970 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series C Preferred Stock |
C - Conversion | −105 744 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series B Preferred Stock |
C - Conversion | −259 642 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series A Preferred Stock |
C - Conversion | −515 909 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
C - Conversion | 1 261 204 | 1 281 244 | 6 293,43 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series F Preferred Stock |
C - Conversion | −1 504 443 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series E Preferred Stock |
C - Conversion | −3 022 681 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series D Preferred Stock |
C - Conversion | −1 727 937 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series C Preferred Stock |
C - Conversion | −2 419 000 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series B Preferred Stock |
C - Conversion | −5 723 870 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series A Preferred Stock |
C - Conversion | −11 373 310 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
C - Conversion | 25 771 241 | 26 626 666 | 3 012,68 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series E Preferred Stock |
C - Conversion | −72 140 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series A Preferred Stock |
C - Conversion | −382 800 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
C - Conversion | 454 940 | 499 478 | 1 021,46 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series C Preferred Stock |
C - Conversion | −85 404 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
C - Conversion | 85 404 | 85 404 | |||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series E Preferred Stock |
C - Conversion | −22 020 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series D Preferred Stock |
C - Conversion | −12 570 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Series B Preferred Stock |
C - Conversion | −192 654 | 0 | −100,00 | ||||
| 2015-10-13 |
|
4 | PSTG |
Pure Storage, Inc.
Class B Common Stock |
C - Conversion | 227 244 | 227 244 | |||||
| 2015-07-06 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
| 2015-02-09 |
|
5 | MATR |
Mattersight Corp
Common Stock |
J - Other | 0 | 92 368 | 0,00 | ||||
| 2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −21 829 | 0 | −100,00 | ||||
| 2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −417 050 | 0 | −100,00 | ||||
| 2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −11 863 | 244 146 | −4,63 | 3,77 | −44 747 | 920 919 | |
| 2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 21 829 | 256 009 | 9,32 | 2,05 | 44 749 | 524 818 | |
| 2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −226 657 | 4 715 398 | −4,59 | 3,77 | −854 950 | 17 786 481 | |
| 2014-10-03 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 417 050 | 4 942 055 | 9,22 | 2,05 | 854 952 | 10 131 213 | |
| 2014-07-01 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
| 2014-06-23 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 028 | 0 | −100,00 | 4,01 | −40 193 | ||
| 2014-06-23 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 960 | 0 | −100,00 | 4,01 | −15 872 | ||
| 2014-06-23 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −10 028 | 0 | −100,00 | 4,01 | −40 193 | ||
| 2014-06-23 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −3 960 | 0 | −100,00 | 4,01 | −15 872 | ||
| 2014-06-16 |
|
4 | MATR |
Mattersight Corp
Series B Preferred Stock |
S - Sale | −22 418 | 0 | −100,00 | 5,82 | −130 473 | ||
| 2014-06-16 |
|
4 | MATR |
Mattersight Corp
Series B Preferred Stock |
S - Sale | −8 854 | 0 | −100,00 | 5,82 | −51 530 | ||
| 2014-06-16 |
|
4 | MATR |
Mattersight Corp
Common Stock |
S - Sale | −14 847 | 0 | −100,00 | 5,12 | −76 017 | ||
| 2014-06-16 |
|
4 | MATR |
Mattersight Corp
Common Stock |
S - Sale | −5 853 | 0 | −100,00 | 5,12 | −29 967 | ||
| 2014-05-19 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
| 2014-03-13 |
|
4/A | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 32 075 | 178 406 | 21,92 | 6,50 | 208 488 | 1 159 639 | |
| 2014-02-13 |
|
5 | MATR |
Mattersight Corp
Common Stock |
J - Other | 0 | 92 368 | 0,00 | ||||
| 2014-02-13 |
|
5 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
J - Other | 0 | 7 000 | 0,00 | ||||
| 2013-12-17 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 32 075 | 178 478 | 21,91 | 6,50 | 208 488 | 1 160 107 | |
| 2013-12-17 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 636 598 | 2 837 826 | 28,92 | 6,50 | 4 137 887 | 18 445 869 | |
| 2013-12-05 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 9 754 | 22 081 | 79,13 | 3,90 | 38 041 | 86 116 | |
| 2013-12-05 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 225 846 | 2 443 889 | 10,18 | 3,90 | 880 799 | 9 531 167 | |
| 2013-11-25 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Convertible Promissory Note |
A - Award | 5 093 000,00 | ||||||
| 2013-11-25 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 46 419 | 46 419 | 6,24 | 289 487 | 289 487 | ||
| 2013-11-25 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 104 670 | 2 201 228 | 4,99 | 6,24 | 652 764 | 13 727 738 | |
| 2013-07-11 |
|
4/A | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
| 2013-07-11 |
|
4/A | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
| 2013-07-11 |
|
4/A | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 12 500 | 12 500 | |||||
| 2013-06-07 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 14 101 | 14 101 | |||||
| 2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −38 747 | 0 | −100,00 | ||||
| 2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock Warrant |
X - Other | −801 952 | 0 | −100,00 | ||||
| 2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −12 589 | 234 180 | −5,10 | 5,72 | −72 059 | 1 340 446 | |
| 2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 38 747 | 246 769 | 18,63 | 1,86 | 72 069 | 458 990 | |
| 2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
S - Sale | −260 592 | 4 525 005 | −5,45 | 5,72 | −1 491 629 | 25 901 129 | |
| 2013-06-04 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
X - Other | 801 952 | 4 785 597 | 20,13 | 1,86 | 1 491 631 | 8 901 210 | |
| 2013-05-31 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Non-Qualified Stock Option |
A - Award | 20 000 | 20 000 | |||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series D Convertible Preferred Stock |
C - Conversion | −4 368 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series C Convertible Preferred Stock |
C - Conversion | −4 958 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series B Convertible Preferred Stock |
C - Conversion | −6 346 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series A Convertible Preferred Stock |
C - Conversion | −20 927 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series D Convertible Preferred Stock |
C - Conversion | −65 818 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series C Convertible Preferred Stock |
C - Conversion | −260 105 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series B Convertible Preferred Stock |
C - Conversion | −208 190 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series A Convertible Preferred Stock |
C - Conversion | −568 711 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series C Convertible Preferred Stock |
C - Conversion | −12 344 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series B Convertible Preferred Stock |
C - Conversion | −7 589 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Series A Convertible Preferred Stock |
C - Conversion | −16 669 | 0 | −100,00 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 4 368 | 36 599 | 13,55 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 4 958 | 32 231 | 18,18 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 6 346 | 27 273 | 30,32 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 20 927 | 20 927 | |||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 65 818 | 1 102 824 | 6,35 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 208 190 | 1 037 006 | 25,12 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 260 105 | 828 816 | 45,74 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 568 711 | 568 711 | |||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 7 589 | 36 602 | 26,16 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 12 344 | 29 013 | 74,05 | ||||
| 2013-05-30 |
|
4 | PTLA |
PORTOLA PHARMACEUTICALS INC
Common Stock |
C - Conversion | 16 669 | 16 669 | |||||
| 2013-05-21 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
| 2013-03-22 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 981 736 | 3 412 793 | 40,38 | 1,05 | 1 030 823 | 3 583 433 | |
| 2013-03-22 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 38 166 | 136 623 | 38,76 | 1,05 | 40 074 | 143 454 | |
| 2013-03-22 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 981 736 | 3 412 793 | 40,38 | 1,05 | 1 030 823 | 3 583 433 | |
| 2013-02-13 |
|
5 | MATR |
Mattersight Corp
Common Stock |
J - Other | 0 | 92 368 | 0,00 | ||||
| 2013-02-13 |
|
5 | MATR |
Mattersight Corp
Common Stock |
J - Other | 0 | 92 368 | 0,00 | ||||
| 2012-09-27 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
P - Purchase | 14 578 | 14 578 | 0,02 | 292 | 292 | ||
| 2012-09-27 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
P - Purchase | 273 100 | 273 100 | 0,02 | 5 462 | 5 462 | ||
| 2012-09-27 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 29 156 | 99 912 | 41,21 | 3,49 | 101 754 | 348 693 | |
| 2012-09-27 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 546 200 | 2 096 558 | 35,23 | 3,49 | 1 906 238 | 7 316 987 | |
| 2012-09-25 |
|
4/A | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
P - Purchase | 1 250 | 1 250 | 0,03 | 39 | 39 | ||
| 2012-09-25 |
|
4/A | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 5 000 | 5 000 | 3,59 | 17 950 | 17 950 | ||
| 2012-09-06 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 185 962 | 2 218 043 | 9,15 | 5,40 | 1 004 846 | 11 985 195 | |
| 2012-09-06 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 8 678 | 12 327 | 237,82 | 5,40 | 46 892 | 66 609 | |
| 2012-09-06 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 185 962 | 2 218 043 | 9,15 | 5,40 | 1 004 846 | 11 985 195 | |
| 2012-08-31 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 18 640 | 2 032 081 | 0,93 | 5,31 | 98 949 | 10 787 099 | |
| 2012-08-31 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 870 | 3 649 | 31,31 | 5,31 | 4 618 | 19 370 | |
| 2012-08-31 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 18 640 | 2 032 081 | 0,93 | 5,31 | 98 949 | 10 787 099 | |
| 2012-08-23 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 920 | 2 779 | 49,49 | 5,00 | 4 600 | 13 895 | |
| 2012-08-23 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 19 682 | 2 013 441 | 0,99 | 5,00 | 98 410 | 10 067 205 | |
| 2012-08-21 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 3 500 | 1 993 759 | 0,18 | 4,81 | 16 837 | 9 591 376 | |
| 2012-08-21 |
|
4 | MATR |
Mattersight Corp
Common Stock |
P - Purchase | 3 500 | 1 993 759 | 0,18 | 4,81 | 16 837 | 9 591 376 | |
| 2012-07-26 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
J - Other | 218 | 703 | 44,95 | ||||
| 2012-07-26 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
J - Other | 136 | 437 | 45,18 | ||||
| 2012-07-26 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
J - Other | 110 | 349 | 46,03 | ||||
| 2012-07-26 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
J - Other | −1 109 | 11 433 | −8,84 | ||||
| 2012-07-26 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
J - Other | −694 | 7 162 | −8,83 | ||||
| 2012-07-26 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
J - Other | −558 | 5 752 | −8,84 | ||||
| 2012-07-26 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
J - Other | 11 721 | 70 756 | 19,85 | ||||
| 2012-07-26 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
J - Other | −59 622 | 1 550 358 | −3,70 | ||||
| 2012-05-21 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
| 2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −280 365 | 0 | −100,00 | 0,12 | −35 046 | ||
| 2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 280 365 | 280 365 | 0,12 | 35 046 | 35 046 | ||
| 2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 280 365 | 5 316 967 | 5,57 | 2,96 | 829 880 | 15 738 222 | |
| 2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
X - Other | −12 643 | 0 | −100,00 | 0,12 | −1 580 | ||
| 2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 12 643 | 12 643 | 0,12 | 1 580 | 1 580 | ||
| 2012-04-02 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
X - Other | 12 643 | 242 210 | 5,51 | 2,96 | 37 423 | 716 942 | |
| 2012-03-06 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
P - Purchase | 5 618 | 5 618 | 0,03 | 175 | 175 | ||
| 2012-03-06 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
P - Purchase | 161 455 | 161 455 | 0,03 | 5 037 | 5 037 | ||
| 2012-03-06 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
P - Purchase | 1 750 | 1 750 | 0,03 | 55 | 55 | ||
| 2012-03-06 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Warrant to Purchase Common Stock |
P - Purchase | 1 250 | 1 250 | 0,03 | 39 | 39 | ||
| 2012-03-06 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 22 473 | 59 035 | 61,47 | 3,59 | 80 678 | 211 936 | |
| 2012-03-06 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 645 820 | 1 609 980 | 66,98 | 3,59 | 2 318 494 | 5 779 828 | |
| 2012-03-06 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 7 000 | 7 000 | 3,59 | 25 130 | 25 130 | ||
| 2012-03-06 |
|
4 | HZNP |
HORIZON PHARMA, INC.
Common Stock |
P - Purchase | 5 000 | 5 000 | 3,59 | 17 950 | 17 950 | ||
| 2012-02-14 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 322 857 | 2 431 057 | 15,31 | 1,65 | 532 714 | 4 011 244 | |
| 2012-02-14 |
|
4 | CRDC |
CARDICA INC
Common Stock |
P - Purchase | 12 893 | 98 457 | 15,07 | 1,65 | 21 273 | 162 454 | |
| 2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
54 547 | ||||||||
| 2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
1 628 | ||||||||
| 2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
643 | ||||||||
| 2010-02-10 | 3 | QNST |
QUINSTREET, INC
Common |
1 114 | ||||||||
| 2009-05-27 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
| 2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 1 836 | 9 595 | 23,66 | 0,12 | 230 | 1 199 | |
| 2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 53 640 | 400 199 | 15,48 | 0,12 | 6 705 | 50 025 | |
| 2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 17 187 | 105 402 | 19,48 | 0,69 | 11 807 | 72 411 | |
| 2009-02-10 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 501 910 | 4 338 742 | 13,08 | 0,69 | 344 812 | 2 980 716 | |
| 2009-01-14 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 10 000 | 10 000 | |||||
| 2008-11-18 |
|
4 | THLD |
THRESHOLD PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 5 000 | 5 000 | |||||
| 2008-11-13 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 1 535 | 88 215 | 1,77 | ||||
| 2008-11-13 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 68 601 | 3 836 832 | 1,82 | ||||
| 2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
3 960 | ||||||||
| 2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
10 028 | ||||||||
| 2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
2 535 249 | ||||||||
| 2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
919 | ||||||||
| 2008-09-08 | 3 | THLD |
THRESHOLD PHARMACEUTICALS INC
Common Stock |
76 419 | ||||||||
| 2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 7 759 | 7 759 | 0,12 | 970 | 970 | ||
| 2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock Warrant |
P - Purchase | 346 559 | 346 559 | 0,12 | 43 320 | 43 320 | ||
| 2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 15 518 | 86 680 | 21,81 | 2,77 | 42 985 | 240 104 | |
| 2008-03-27 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 693 118 | 3 768 231 | 22,54 | 2,77 | 1 919 937 | 10 438 000 | |
| 2007-11-29 | 3/A | ELOY |
ELOYALTY CORP
Common Stock |
3 768 | ||||||||
| 2007-11-29 | 3/A | ELOY |
ELOYALTY CORP
Common Stock |
9 555 | ||||||||
| 2007-11-29 | 3/A | ELOY |
ELOYALTY CORP
Common Stock |
383 185 | ||||||||
| 2007-11-29 | 3/A | ELOY |
ELOYALTY CORP
Common Stock |
3 259 | ||||||||
| 2007-09-25 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | 59 512 | 71 162 | 510,83 | ||||
| 2007-09-25 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −468 492 | 3 075 113 | −13,22 | ||||
| 2007-08-21 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 533 | 11 650 | 4,79 | 2,10 | 1 119 | 24 465 | |
| 2007-08-21 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 162 218 | 3 543 605 | 4,80 | 2,10 | 340 658 | 7 441 570 | |
| 2007-06-08 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 2 602 | 11 117 | 30,56 | 1,00 | 2 602 | 11 117 | |
| 2007-06-08 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 791 347 | 3 381 387 | 30,55 | 1,00 | 791 347 | 3 381 387 | |
| 2007-06-08 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 17 345 | 74 113 | 30,55 | 1,00 | 17 345 | 74 113 | |
| 2007-06-08 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 6 851 | 29 273 | 30,55 | 1,00 | 6 851 | 29 273 | |
| 2006-12-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 5 059 | 8 515 | 146,38 | 1,00 | 5 059 | 8 515 | |
| 2006-12-15 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
P - Purchase | 379 391 | 2 590 040 | 17,16 | 1,00 | 379 391 | 2 590 040 | |
| 2005-12-12 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
J - Other | −5 539 | 2 210 649 | −0,25 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series B Preferred Stock |
C - Conversion | −189 980 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series B Preferred Stock |
C - Conversion | −4 873 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series B Preferred Stock |
C - Conversion | −1 925 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −263 862 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −6 768 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series A Preferred Stock |
C - Conversion | −2 673 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −3 456 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −732 882 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −18 736 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series C Preferred Stock |
C - Conversion | −7 400 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −121 780 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −3 109 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Series BB Preferred Stock |
C - Conversion | −1 228 | 0 | −100,00 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 3 456 | 3 456 | |||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 732 882 | 2 216 188 | 49,41 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 569 940 | 1 483 306 | 62,40 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 121 780 | 913 366 | 15,38 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 791 586 | 791 586 | |||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 18 736 | 56 768 | 49,26 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 14 619 | 38 032 | 62,44 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 3 109 | 23 413 | 15,31 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 20 304 | 20 304 | |||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 7 400 | 22 422 | 49,26 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 5 775 | 15 022 | 62,45 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 1 228 | 9 247 | 15,31 | ||||
| 2004-04-19 |
|
4 | CORT |
CORCEPT THERAPEUTICS INC
Common Stock |
C - Conversion | 8 019 | 8 019 |
